BSX logo

Boston Scientific (BSX) EBIT

annual EBIT:

$2.59B+$337.00M(+14.98%)
December 1, 2024

Summary

  • As of today (April 18, 2025), BSX annual earnings before interest & taxes is $2.59 billion, with the most recent change of +$337.00 million (+14.98%) on December 1, 2024.
  • During the last 3 years, BSX annual EBIT has risen by +$1.17 billion (+82.57%).
  • BSX annual EBIT is now at all-time high.

Performance

BSX EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBSXincome statement metrics

quarterly EBIT:

$665.00M-$83.00M(-11.10%)
December 1, 2024

Summary

  • As of today (April 18, 2025), BSX quarterly earnings before interest & taxes is $665.00 million, with the most recent change of -$83.00 million (-11.10%) on December 1, 2024.
  • Over the past year, BSX quarterly EBIT has dropped by -$83.00 million (-11.10%).
  • BSX quarterly EBIT is now -11.10% below its all-time high of $748.00 million, reached on September 30, 2024.

Performance

BSX quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBSXincome statement metrics

TTM EBIT:

$2.59B+$95.00M(+3.81%)
December 1, 2024

Summary

  • As of today (April 18, 2025), BSX TTM earnings before interest & taxes is $2.59 billion, with the most recent change of +$95.00 million (+3.81%) on December 1, 2024.
  • Over the past year, BSX TTM EBIT has increased by +$95.00 million (+3.81%).
  • BSX TTM EBIT is now at all-time high.

Performance

BSX TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBSXincome statement metrics

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

BSX EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+15.0%-11.1%+3.8%
3 y3 years+82.6%+34.1%+45.9%
5 y5 years+123.0%+34.1%+45.9%

BSX EBIT Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+82.6%-11.1%+115.9%at high+90.5%
5 y5-yearat high+817.4%-11.1%+571.6%at high+4875.0%
alltimeall timeat high+167.3%-11.1%+118.7%at high+159.3%

Boston Scientific EBIT History

DateAnnualQuarterlyTTM
Dec 2024
$2.59B(+15.0%)
$665.00M(-11.1%)
$2.59B(+3.8%)
Sep 2024
-
$748.00M(+50.5%)
$2.49B(+3.0%)
Jun 2024
-
$497.00M(-26.6%)
$2.42B(+0.0%)
Mar 2024
-
$677.00M(+18.8%)
$2.42B(+7.5%)
Dec 2023
$2.25B(+39.7%)
$570.00M(-15.7%)
$2.25B(+5.1%)
Sep 2023
-
$676.00M(+36.3%)
$2.14B(+20.8%)
Jun 2023
-
$496.00M(-2.6%)
$1.77B(+5.2%)
Mar 2023
-
$509.00M(+10.7%)
$1.69B(+4.6%)
Dec 2022
$1.61B(+13.7%)
$460.00M(+49.4%)
$1.61B(+18.7%)
Sep 2022
-
$308.00M(-24.7%)
$1.36B(-16.1%)
Jun 2022
-
$409.00M(-6.0%)
$1.62B(+12.0%)
Mar 2022
-
$435.00M(+111.2%)
$1.45B(+2.0%)
Dec 2021
$1.42B(+402.5%)
$206.00M(-63.8%)
$1.42B(-12.2%)
Sep 2021
-
$569.00M(+142.1%)
$1.61B(+78.5%)
Jun 2021
-
$235.00M(-42.3%)
$904.00M(+56.1%)
Mar 2021
-
$407.00M(+1.0%)
$579.00M(+105.3%)
Dec 2020
$282.00M(-75.7%)
$403.00M(-385.8%)
$282.00M(+442.3%)
Sep 2020
-
-$141.00M(+56.7%)
$52.00M(-86.3%)
Jun 2020
-
-$90.00M(-181.8%)
$379.00M(-46.1%)
Mar 2020
-
$110.00M(-36.4%)
$703.00M(-39.3%)
Dec 2019
$1.16B(-30.2%)
$173.00M(-7.0%)
$1.16B(-13.9%)
Sep 2019
-
$186.00M(-20.5%)
$1.35B(-19.6%)
Jun 2019
-
$234.00M(-58.7%)
$1.67B(-9.2%)
Mar 2019
-
$566.00M(+57.2%)
$1.84B(+11.0%)
Dec 2018
$1.66B(+43.1%)
$360.00M(-30.0%)
$1.66B(+4.8%)
Sep 2018
-
$514.00M(+27.2%)
$1.59B(+10.3%)
Jun 2018
-
$404.00M(+5.2%)
$1.44B(+21.6%)
Mar 2018
-
$384.00M(+35.2%)
$1.18B(+1.9%)
Dec 2017
$1.16B(+183.4%)
$284.00M(-22.4%)
$1.16B(+13.4%)
Sep 2017
-
$366.00M(+145.6%)
$1.02B(+5.2%)
Jun 2017
-
$149.00M(-58.8%)
$973.00M(+100.2%)
Mar 2017
-
$362.00M(+146.3%)
$486.00M(+18.2%)
Dec 2016
$410.00M(-212.0%)
$147.00M(-53.3%)
$411.00M(-2840.0%)
Sep 2016
-
$315.00M(-193.2%)
-$15.00M(-97.7%)
Jun 2016
-
-$338.00M(-217.8%)
-$639.00M(+610.0%)
Mar 2016
-
$287.00M(-202.9%)
-$90.00M(-75.5%)
Dec 2015
-$366.00M(+24.9%)
-$279.00M(-9.7%)
-$368.00M(-37.4%)
Sep 2015
-
-$309.00M(-246.4%)
-$588.00M(+164.9%)
Jun 2015
-
$211.00M(+2244.4%)
-$222.00M(-54.1%)
Mar 2015
-
$9.00M(-101.8%)
-$484.00M(+65.2%)
Dec 2014
-$293.00M(-390.1%)
-$499.00M(-975.4%)
-$293.00M(-190.7%)
Sep 2014
-
$57.00M(-211.8%)
$323.00M(-11.0%)
Jun 2014
-
-$51.00M(-125.5%)
$363.00M(-42.5%)
Mar 2014
-
$200.00M(+70.9%)
$631.00M(+518.6%)
Dec 2013
$101.00M(-102.6%)
$117.00M(+20.6%)
$102.00M(+1.0%)
Sep 2013
-
$97.00M(-55.3%)
$101.00M(-117.0%)
Jun 2013
-
$217.00M(-166.0%)
-$594.00M(-86.4%)
Mar 2013
-
-$329.00M(-383.6%)
-$4.37B(+13.6%)
Dec 2012
-$3.85B(-516.7%)
$116.00M(-119.4%)
-$3.84B(+1.5%)
Sep 2012
-
-$598.00M(-83.2%)
-$3.79B(+25.5%)
Jun 2012
-
-$3.55B(-1951.0%)
-$3.02B(-493.5%)
Mar 2012
-
$192.00M(+12.3%)
$767.00M(-16.9%)
Dec 2011
$923.00M(-237.8%)
$171.00M(-1.2%)
$923.00M(-15.2%)
Sep 2011
-
$173.00M(-25.1%)
$1.09B(-6.9%)
Jun 2011
-
$231.00M(-33.6%)
$1.17B(+0.8%)
Mar 2011
-
$348.00M(+3.6%)
$1.16B(-273.1%)
Dec 2010
-$670.00M(-25.6%)
$336.00M(+32.3%)
-$670.00M(-70.0%)
Sep 2010
-
$254.00M(+14.4%)
-$2.23B(-8.5%)
Jun 2010
-
$222.00M(-115.0%)
-$2.44B(+2.1%)
Mar 2010
-
-$1.48B(+21.0%)
-$2.39B(+165.0%)
Dec 2009
-$901.00M(-42.4%)
-$1.23B(-2706.4%)
-$901.00M(-57.0%)
Sep 2009
-
$47.00M(-82.7%)
-$2.09B(-0.1%)
Jun 2009
-
$272.00M(+5340.0%)
-$2.10B(+2.8%)
Mar 2009
-
$5.00M(-100.2%)
-$2.04B(+21.9%)
Dec 2008
-$1.56B(<-9900.0%)
-$2.42B(-5595.5%)
-$1.67B(-748.4%)
Sep 2008
-
$44.00M(-86.6%)
$258.00M(+81.7%)
Jun 2008
-
$329.00M(-11.6%)
$142.00M(+67.1%)
Mar 2008
-
$372.00M(-176.4%)
$85.00M(-1800.0%)
DateAnnualQuarterlyTTM
Dec 2007
$1.00M(-99.9%)
-$487.00M(+576.4%)
-$5.00M(-100.7%)
Sep 2007
-
-$72.00M(-126.5%)
$768.00M(-25.8%)
Jun 2007
-
$272.00M(-3.5%)
$1.03B(+8.4%)
Mar 2007
-
$282.00M(-1.4%)
$955.00M(-18.4%)
Dec 2006
$1.17B(-5.9%)
$286.00M(+46.7%)
$1.17B(-13.3%)
Sep 2006
-
$195.00M(+1.6%)
$1.35B(+64.9%)
Jun 2006
-
$192.00M(-61.4%)
$818.00M(-29.2%)
Mar 2006
-
$497.00M(+6.9%)
$1.16B(-7.2%)
Dec 2005
$1.24B(-24.1%)
$465.00M(-238.4%)
$1.24B(-3.1%)
Sep 2005
-
-$336.00M(-163.5%)
$1.28B(-35.1%)
Jun 2005
-
$529.00M(-9.7%)
$1.98B(+0.9%)
Mar 2005
-
$586.00M(+16.0%)
$1.96B(+19.6%)
Dec 2004
$1.64B(+123.3%)
$505.00M(+41.1%)
$1.64B(+22.9%)
Sep 2004
-
$358.00M(-30.1%)
$1.33B(+15.3%)
Jun 2004
-
$512.00M(+93.9%)
$1.16B(+39.4%)
Mar 2004
-
$264.00M(+32.0%)
$830.00M(+13.1%)
Dec 2003
$734.00M(+5.6%)
$200.00M(+10.5%)
$734.00M(+0.4%)
Sep 2003
-
$181.00M(-2.2%)
$731.00M(-8.2%)
Jun 2003
-
$185.00M(+10.1%)
$796.00M(+7.9%)
Mar 2003
-
$168.00M(-14.7%)
$738.00M(+6.2%)
Dec 2002
$695.00M(+81.9%)
$197.00M(-19.9%)
$695.00M(-21.4%)
Sep 2002
-
$246.00M(+93.7%)
$884.00M(+19.5%)
Jun 2002
-
$127.00M(+1.6%)
$740.00M(+13.0%)
Mar 2002
-
$125.00M(-67.6%)
$655.00M(+0.9%)
Dec 2001
$382.00M(-43.4%)
$386.00M(+278.4%)
$649.00M(+61.8%)
Sep 2001
-
$102.00M(+142.9%)
$401.00M(-13.6%)
Jun 2001
-
$42.00M(-64.7%)
$464.00M(-24.4%)
Mar 2001
-
$119.00M(-13.8%)
$614.00M(-9.0%)
Dec 2000
$675.00M(-6.9%)
$138.00M(-16.4%)
$675.00M(-7.7%)
Sep 2000
-
$165.00M(-14.1%)
$731.00M(+7.0%)
Jun 2000
-
$192.00M(+6.7%)
$683.00M(-3.3%)
Mar 2000
-
$180.00M(-7.2%)
$706.00M(-2.6%)
Dec 1999
$725.00M(+47.7%)
$194.00M(+65.8%)
$725.00M(+4.8%)
Sep 1999
-
$117.00M(-45.6%)
$692.00M(-0.3%)
Jun 1999
-
$215.00M(+8.0%)
$694.00M(+18.2%)
Mar 1999
-
$199.00M(+23.6%)
$587.00M(+19.6%)
Dec 1998
$491.00M(+16.4%)
$161.00M(+35.3%)
$491.00M(+30.7%)
Sep 1998
-
$119.00M(+10.2%)
$375.80M(-1.4%)
Jun 1998
-
$108.00M(+4.9%)
$381.30M(-7.5%)
Mar 1998
-
$103.00M(+124.9%)
$412.10M(-2.3%)
Dec 1997
$422.00M(+22.1%)
$45.80M(-63.2%)
$421.90M(+8.3%)
Sep 1997
-
$124.50M(-10.3%)
$389.50M(+4.1%)
Jun 1997
-
$138.80M(+23.0%)
$374.10M(+6.6%)
Mar 1997
-
$112.80M(+741.8%)
$350.90M(+16.0%)
Dec 1996
$345.50M(+34.7%)
$13.40M(-87.7%)
$302.50M(-4.8%)
Sep 1996
-
$109.10M(-5.6%)
$317.60M(+10.6%)
Jun 1996
-
$115.60M(+79.5%)
$287.20M(+16.4%)
Mar 1996
-
$64.40M(+126.0%)
$246.80M(-3.8%)
Dec 1995
$256.50M(+97.3%)
$28.50M(-63.8%)
$256.60M(-3.5%)
Sep 1995
-
$78.70M(+4.7%)
$265.90M(+21.4%)
Jun 1995
-
$75.20M(+1.3%)
$219.00M(+25.5%)
Mar 1995
-
$74.20M(+96.3%)
$174.50M(+34.2%)
Dec 1994
$130.00M(+19.7%)
$37.80M(+18.9%)
$130.00M(+4.9%)
Sep 1994
-
$31.80M(+3.6%)
$123.90M(+4.0%)
Jun 1994
-
$30.70M(+3.4%)
$119.10M(+3.9%)
Mar 1994
-
$29.70M(-6.3%)
$114.60M(+5.6%)
Dec 1993
$108.60M(+17.0%)
$31.70M(+17.4%)
$108.50M(+6.1%)
Sep 1993
-
$27.00M(+3.1%)
$102.30M(+2.6%)
Jun 1993
-
$26.20M(+11.0%)
$99.70M(+4.4%)
Mar 1993
-
$23.60M(-7.5%)
$95.50M(+2.8%)
Dec 1992
$92.80M(+31.6%)
$25.50M(+4.5%)
$92.90M(-428.3%)
Sep 1992
-
$24.40M(+10.9%)
-$28.30M(-493.1%)
Jun 1992
-
$22.00M(+4.8%)
$7.20M(-82.5%)
Mar 1992
-
$21.00M(-121.9%)
$41.10M(-41.8%)
Dec 1991
$70.50M
-$95.70M(-259.8%)
$70.60M(-57.5%)
Sep 1991
-
$59.90M(+7.2%)
$166.30M(+56.3%)
Jun 1991
-
$55.90M(+10.7%)
$106.40M(+110.7%)
Mar 1991
-
$50.50M
$50.50M

FAQ

  • What is Boston Scientific annual earnings before interest & taxes?
  • What is the all time high annual EBIT for Boston Scientific?
  • What is Boston Scientific annual EBIT year-on-year change?
  • What is Boston Scientific quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for Boston Scientific?
  • What is Boston Scientific quarterly EBIT year-on-year change?
  • What is Boston Scientific TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for Boston Scientific?
  • What is Boston Scientific TTM EBIT year-on-year change?

What is Boston Scientific annual earnings before interest & taxes?

The current annual EBIT of BSX is $2.59B

What is the all time high annual EBIT for Boston Scientific?

Boston Scientific all-time high annual earnings before interest & taxes is $2.59B

What is Boston Scientific annual EBIT year-on-year change?

Over the past year, BSX annual earnings before interest & taxes has changed by +$337.00M (+14.98%)

What is Boston Scientific quarterly earnings before interest & taxes?

The current quarterly EBIT of BSX is $665.00M

What is the all time high quarterly EBIT for Boston Scientific?

Boston Scientific all-time high quarterly earnings before interest & taxes is $748.00M

What is Boston Scientific quarterly EBIT year-on-year change?

Over the past year, BSX quarterly earnings before interest & taxes has changed by -$83.00M (-11.10%)

What is Boston Scientific TTM earnings before interest & taxes?

The current TTM EBIT of BSX is $2.59B

What is the all time high TTM EBIT for Boston Scientific?

Boston Scientific all-time high TTM earnings before interest & taxes is $2.59B

What is Boston Scientific TTM EBIT year-on-year change?

Over the past year, BSX TTM earnings before interest & taxes has changed by +$95.00M (+3.81%)
On this page